The American Journal of Medicine
Volume 119, Issue 11, Supplement 1 , Pages S16-S19 , November 2006

Discussion Following Cases 4 and 5

  • Joseph D. Croft, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Joseph D. Croft, MD, 5530 Wisconsin Avenue, Suite 1150, Chevy Chase, Maryland 20815.

References 

  1. Popp JD, Edwards NL. New insights into gouty arthritis. Contemp Intern Med. 1995;7:55–64
  2. Croft JD. Case 4: chronic synovitis secondary to gout. Am J Med. 2006;119:S13
  3. Croft JD. Case 5: treatment options for acute gout. Am J Med. 2006;119:S14–S15
  4. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis in gout: prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med. 1961;55:179–192
  5. Terkeltaub RA. Gout [Clinical practice]. N Engl J Med. 2003;349:1647–1655
  6. Bellamy N, Downie WW, Buchanan WW. Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol. 1987;24:33–36
  7. Weiner GI, White SR, Weitzner RI, Rubinstein HM. Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis. Arthritis Rheum. 1979;22:425–426
  8. Shrestha M, Morgan DL, Moreden JM, Singh R, Nelson M, Hayes JE. Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Ann Emerg Med. 1995;26:682–686
  9. Maccagno A, Di Giorgio E, Romanowicz A. Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout. Curr Med Res Opin. 1991;12:423–429
  10. Smyth CJ, Percy JS. Comparison of indomethacin and phenylbutazone in acute gout. Ann Rheum Dis. 1973;32:351–353
  11. Altman RD, Honig S, Levin JM, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. J Rheumatol. 1988;15:1422–1426
  12. Schumacher HR, Boice JA, Daikh DI, et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ. 2002;324:1488–1492
  13. Emmerson BT. The management of gout. N Engl J Med. 1996;334:445–451
  14. Roberts WN, Liang MH, Stern SH. Colchicine in acute gout: reassessment of risks and benefits. JAMA. 1987;257:1920–1922
  15. Bonnel RA, Villalba ML, Karwoski CB, Beitz J. Deaths associated with inappropriate intravenous colchicine administration. J Emerg Med. 2002;22:385–387
  16. Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? (The results of the first controlled study in acute gout). Aust N Z J Med. 1987;17:301–304
  17. Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum. 1981;10:231–254
  18. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19:329–336
  19. Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol. 1993;20:111–113

PII: S0002-9343(06)00755-8

doi: 10.1016/j.amjmed.2006.06.020

The American Journal of Medicine
Volume 119, Issue 11, Supplement 1 , Pages S16-S19 , November 2006

Article Tools